These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

971 related items for PubMed ID: 29621426

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
    Yu J, Du W, Yan F, Wang Y, Li H, Cao S, Yu W, Shen C, Liu J, Ren X.
    J Immunol; 2013 Apr 01; 190(7):3783-97. PubMed ID: 23440412
    [Abstract] [Full Text] [Related]

  • 3. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
    Li F, Sun Y, Huang J, Xu W, Liu J, Yuan Z.
    Cancer Med; 2019 Dec 01; 8(17):7330-7344. PubMed ID: 31631566
    [Abstract] [Full Text] [Related]

  • 4. Prognosis significance of indoleamine 2, 3-dioxygenase, programmed death ligand-1 and tumor-infiltrating immune cells in microenvironment of breast cancer.
    Wei L, Wu N, Wei F, Li F, Zhang Y, Liu J, Ren X.
    Int Immunopharmacol; 2020 Jul 01; 84():106506. PubMed ID: 32330866
    [Abstract] [Full Text] [Related]

  • 5. Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients.
    Papadaki MA, Aggouraki D, Vetsika EK, Xenidis N, Kallergi G, Kotsakis A, Georgoulias V.
    Anticancer Res; 2021 Feb 01; 41(2):661-670. PubMed ID: 33517270
    [Abstract] [Full Text] [Related]

  • 6. Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment.
    Schafer CC, Wang Y, Hough KP, Sawant A, Grant SC, Thannickal VJ, Zmijewski J, Ponnazhagan S, Deshane JS.
    Oncotarget; 2016 Nov 15; 7(46):75407-75424. PubMed ID: 27705910
    [Abstract] [Full Text] [Related]

  • 7. The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study.
    Salmi S, Lin A, Hirschovits-Gerz B, Valkonen M, Aaltonen N, Sironen R, Siiskonen H, Pasonen-Seppänen S.
    BMC Cancer; 2021 May 29; 21(1):641. PubMed ID: 34051744
    [Abstract] [Full Text] [Related]

  • 8. Chemoresistance was correlated with elevated expression and activity of indoleamine 2,3-dioxygenase in breast cancer.
    Zhao Y, Wei L, Liu J, Li F.
    Cancer Chemother Pharmacol; 2020 Jan 29; 85(1):77-93. PubMed ID: 31844921
    [Abstract] [Full Text] [Related]

  • 9. Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs.
    Demir L, Yigit S, Ellidokuz H, Erten C, Somali I, Kucukzeybek Y, Alacacioglu A, Cokmert S, Can A, Akyol M, Dirican A, Bayoglu V, Sari AA, Tarhan MO.
    Clin Exp Metastasis; 2013 Dec 29; 30(8):1047-62. PubMed ID: 23836289
    [Abstract] [Full Text] [Related]

  • 10. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
    Kim ST, Jeong H, Woo OH, Seo JH, Kim A, Lee ES, Shin SW, Kim YH, Kim JS, Park KH.
    Am J Clin Oncol; 2013 Jun 29; 36(3):224-31. PubMed ID: 22495453
    [Abstract] [Full Text] [Related]

  • 11. Clinicopathological significance of the immunologic signature (PDL1, FOXP3+ Tregs, TILs) in early stage triple-negative breast cancer treated with neoadjuvant chemotherapy.
    Abdelrahman AE, Rashed HE, MostafaToam, Omar A, Abdelhamid MI, Matar I.
    Ann Diagn Pathol; 2021 Apr 29; 51():151676. PubMed ID: 33360026
    [Abstract] [Full Text] [Related]

  • 12. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.
    Stenström J, Hedenfalk I, Hagerling C.
    Breast Cancer Res; 2021 Feb 18; 23(1):27. PubMed ID: 33602289
    [Abstract] [Full Text] [Related]

  • 13. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients.
    Safarzadeh E, Mohammadi A, Mansoori B, Duijf PHG, Hashemzadeh S, Khaze V, Kazemi T, Derakhshani A, Silvestris N, Baradaran B.
    Front Immunol; 2020 Feb 18; 11():613215. PubMed ID: 33679700
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status.
    Chung YR, Kim HJ, Jang MH, Park SY.
    Breast Cancer Res Treat; 2017 Feb 18; 161(3):409-420. PubMed ID: 27913931
    [Abstract] [Full Text] [Related]

  • 15. Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma.
    Siret C, Collignon A, Silvy F, Robert S, Cheyrol T, André P, Rigot V, Iovanna J, van de Pavert S, Lombardo D, Mas E, Martirosyan A.
    Front Immunol; 2019 Feb 18; 10():3070. PubMed ID: 32038621
    [Abstract] [Full Text] [Related]

  • 16. Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.
    Syed Khaja AS, Toor SM, El Salhat H, Faour I, Ul Haq N, Ali BR, Elkord E.
    Oncotarget; 2017 May 16; 8(20):33159-33171. PubMed ID: 28388539
    [Abstract] [Full Text] [Related]

  • 17. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
    Safarzadeh E, Hashemzadeh S, Duijf PHG, Mansoori B, Khaze V, Mohammadi A, Kazemi T, Yousefi M, Asadi M, Mohammadi H, Babaie F, Baradaran B.
    J Cell Physiol; 2019 Apr 16; 234(4):3515-3525. PubMed ID: 30362521
    [Abstract] [Full Text] [Related]

  • 18. Noncanonical NF-κB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer.
    Yu J, Wang Y, Yan F, Zhang P, Li H, Zhao H, Yan C, Yan F, Ren X.
    J Immunol; 2014 Sep 01; 193(5):2574-86. PubMed ID: 25063873
    [Abstract] [Full Text] [Related]

  • 19. Investigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia: A Systematic Review.
    Wells G, Kennedy PT, Dahal LN.
    Front Immunol; 2021 Sep 01; 12():651687. PubMed ID: 33777052
    [Abstract] [Full Text] [Related]

  • 20. Upregulated expression of indoleamine 2, 3-dioxygenase in primary breast cancer correlates with increase of infiltrated regulatory T cells in situ and lymph node metastasis.
    Yu J, Sun J, Wang SE, Li H, Cao S, Cong Y, Liu J, Ren X.
    Clin Dev Immunol; 2011 Sep 01; 2011():469135. PubMed ID: 22110525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.